|
Neonatal Intensive Care Drug Manual
|
| bet | 213/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Flucloxacillin
Revision Date : 16-11-2020
|
Approved: TC, KOH
|
Alert
|
S4 High risk medicine.
Antimicrobial Stewardship Team listed this drug as unrestricted.
|
Indication
|
Treatment of sepsis where infection by Staphylococcus aureus or susceptible coagulase-negative Staphylococci (CoNS) is suspected or confirmed, and other infections caused by susceptible organisms.
|
Action
|
Bactericidal agent that works by inhibiting the biosynthesis of cell wall mucopeptides. Flucloxacillin is stable against beta-lactamase producing Staphylococci.
|
Drug type
|
Penicillin antibiotic.
|
Trade name
|
Flucil, Flucloxacillin sodium monohydrate for injection (DBL), Flubiclox
|
Presentation
|
500 mg vial, 1000 mg vial, 125 mg/5 mL suspension, 250 mg/5 mL suspension.
|
Dose/interval
|
|
|
| |
